In a significant medical breakthrough, a team at the National Children's Medical Center and Shanghai Children's Medical Center (affiliated with Shanghai Jiao Tong University School of Medicine) has successfully performed an ABO-incompatible heart transplant on an 11-month-old infant. The procedure, the first of its kind in Shanghai for a patient of this age, bypasses the traditional requirement for donor-recipient blood type matching, offering new hope for young children with end-stage heart failure.

A Race Against Time

The recipient, an infant nicknamed Xixi weighing just 8 kilograms, was diagnosed with restrictive cardiomyopathy—a rare and severe condition—after developing sudden, systemic edema. At Shanghai Children's Medical Center, tests revealed critically impaired heart function, with biomarker levels soaring far beyond normal limits. After two weeks of intensive treatment yielded no improvement, a heart transplant became her only chance of survival.

A Donor Heart Appears, But With a Crucial Hurdle

Finding a donor heart for a small child is notoriously difficult, akin to searching for a needle in a haystack. Just as hope seemed to be fading, a suitable donor heart became available through the National Organ Allocation System. It was an ideal match in size and weight. However, a major obstacle remained: the donor had type B blood, while Xixi had type A. Traditionally, such an ABO incompatibility is an absolute barrier to transplantation, as it risks triggering a rapid, fatal immune rejection.

Faced with this stark choice, the medical team, led by Director Zhu Zhongqun, made a bold decision to proceed.

A Pioneering Procedure

The team leveraged a critical physiological insight: infants under two years old have immature immune systems with a limited capacity to produce strong antibodies. This creates a brief "golden window" where the rules of transplantation can be carefully rewritten. By employing a precise protocol to manage the immune response, they successfully transplanted the donor heart.